Innocan Pharma Unveils Groundbreaking Veterinary Breakthroughs at EAVPT 2023 Congress

HERZLIYA, Israel and CALGARY, AB, June 22, 2023 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF), a leading innovator in pharmaceutical solutions for Human & Animal health, proudly announces its participation in the 15th International Congress organized by…

Click here to view original post